Lupron Depot (leuprolide acetate) — Medica
Head and Neck Cancer – Salivary Gland Tumors
Initial criteria
- Patient has recurrent, unresectable, or metastatic disease; AND
- Patient has androgen receptor-positive disease; AND
- Medication is prescribed by or in consultation with an oncologist.
Approval duration
1 year